跳至主要内容
临床试验/NCT01197898
NCT01197898已完成4 期

Evaluation of the Edge of Non-Healing Cutaneous Ulcers Following Debridement With Collagenase Santyl Ointment

Healthpoint2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Healthpoint
入组人数
10
试验地点
2
主要终点
Change From Baseline in Extent of Presence/Absence of Epithelial Tongue.

研究概览

简要总结

The goal of this study is to evaluate changes in the healing tissue of diabetic foot wounds following 14 days of treatment with Santyl or its vehicle base.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • To be eligible for the study, subjects must meet the following inclusion criteria:
  • Subjects should be presenting for the first time with a complaint of a non-healing wound, or may have failed one or more prior inadequate therapies. To improve homogeneity in the group studied, subjects with large wounds, complicated wounds, wounds of long duration, or who have failed multiple attempts at healing in which additional known critical variables were addressed (debridement, off loading, wound moisture control, wound infection control, blood glucose control, and/or adequate local blood supply) will be excluded.
  • Provide written informed consent.
  • Subjects 18 years of age or older, of either sex and of any race, with an existing diagnosis of Type I or Type II Diabetes Mellitus.
  • Presenting for the first time with a complaint of a non-healing wound, or may have failed one or more prior inadequate therapies but not including therapies generally reserved for chronic wounds (i.e., debridement, off loading, wound moisture control, wound infection control, blood glucose control, and/or adequate local blood supply).
  • Willing to attend all required study visits, and in the opinion of the Investigator, able to properly follow instructions regarding daily dressing changes (dressing changes may be done by a third party, who must agree to perform these daily).
  • Body Mass Index less than or equal to 40
  • A foot wound which meets the following criteria:
  • Time since initial skin breakdown 56 - 112 days
  • Wagner† Grade 1
  • Area between 0.75 and 3.0 cm2, inclusive
  • Located on plantar surface of midfoot or forefoot, dorsum of foot, or a post-amputation wound
  • Non-infected based on clinical assessment
  • Adequate blood supply to the affected foot, defined as meeting a transcutaneous oxygen pressure(TcPO2) measured using standard technique and within 4 cm of the wound of greater than or equal to 35 mmHg.
  • Blood chemistry and hematology values as follows, using local lab normal ranges unless otherwise specified:
  • Blood Glycated Hemoglobin (HbA1C) 6.5 - 10.5%
  • Blood Glucose less than or equal to 180 mg/dL
  • Blood Hemoglobin, Hematocrit, Red Blood Cell count within normal limits
  • Serum Sodium, Potassium, Calcium, Phosphorus, Carbon Dioxide (CO2) within normal limits
  • Serum Albumin greater than or equal to 2.0 g/dL, serum Pre-Albumin greater than or equal to 15 mg/dL
  • Alanine Transaminase (ALT), Aspartate Transaminase (AST), Gamma Glutamyl Transpeptidase (GGT) less than or equal to 2.0 x Upper Limit of Normal (ULN)
  • Blood Urea Nitrogen, Total Bilirubin, Creatinine less than or equal to 1.5 x ULN
  • Wound is able to be off-loaded, if indicated. † Wagner Grade 1 = Superficial ulcer, partial or full-thickness, but not involving underlying fat, fascia, tendon, muscle or bone.

排除标准

  • Subjects meeting any of the following criteria during the screening period will be excluded from the study:
  • Contraindications or hypersensitivity to the use of the study medications or their components
  • Therapy with another investigational agent within thirty (30) days of Visit
  • Calluses or maceration of periwound area which would interfere with successful biopsy of the wound edge.
  • Undermining or tunneling of the target wound.
  • Evidence of osteomyelitis on screening roentgenogram of the target foot.
  • Coagulation defect or bleeding disorder which, in the opinion of the Investigator, will make the biopsy procedures too risky.
  • The Medical Monitor may declare any subject ineligible for a valid medical reason.

结局指标

主要结局

Change From Baseline in Extent of Presence/Absence of Epithelial Tongue.

时间窗: 28 Days

The results were found to be inconclusive due to the small number of biopsy specimens of sufficient quality for analysis. Four of the 10 subjects enrolled were not evaluable due to poor biopsy quality.

次要结局

未报告次要终点

研究者

发起方
Healthpoint
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验